Industry PharmaceuticalsOther
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| RECAX | 12.44 | -0.01 | -0.08% |
| RBC Emerging Markets Ex-China Equity A | |||
| AAUTX | 32.17 | -0.04 | -0.12% |
| Thrivent Large Cap Value A | |||
| VVICX | 12.25 | -0.17 | -1.37% |
| VOYA VACS Index Series SC Portfolio | |||
| CRTVX | 11.99 | -0.18 | -1.48% |
| Catholic Rsp Invst Mlt-Styl US Eq Inv | |||
| PAULX | 44.11 | -0.68 | -1.52% |
| T. Rowe Price US Large-Cap Core Adv | |||
A.I.dvisor tells us that PCYN and NXEN have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCYN and NXEN's prices will move in lockstep.
| Ticker / NAME | Correlation To PCYN | 1D Price Change % | ||
|---|---|---|---|---|
| PCYN | 100% | N/A | ||
| NXEN - PCYN | 11% Poorly correlated | N/A | ||
| RSCI - PCYN | 5% Poorly correlated | -8.83% | ||
| PHCUF - PCYN | 5% Poorly correlated | +16.07% | ||
| OMID - PCYN | 5% Poorly correlated | N/A | ||
| ROMJF - PCYN | 3% Poorly correlated | -3.44% | ||
More | ||||